B
BTIG Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
401
The RMR Group
RMR
$284M
| $16.86 | $45 |
167%
upside
| Buy |
28 Dec ‘20
4 years ago |
|
|
|
IMDX
402
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$76.4M
|
MM
Mark Massaro
| $2.67 | $100 |
3,645%
upside
| Buy |
30 Nov ‘20
4 years ago |
|
403
AGNC Investment
AGNC
$10.8B
|
EH
Eric Hagen
| $10.35 | $16.50 |
59%
upside
| Buy |
24 Nov ‘20
4 years ago |
|
404
Biodesix
BDSX
$68.1M
| $0.4642 | $22 |
4,639%
upside
| Buy |
23 Nov ‘20
4 years ago |
|
|
405
Replimune Group
REPL
$454M
| $5.82 | $60 |
931%
upside
| Buy |
17 Nov ‘20
4 years ago |
|
|
406
Donnelley Financial Solutions
DFIN
$1.53B
|
MP
Mark Palmer
| $55.73 | $17 |
70%
downside
| Buy |
5 Nov ‘20
4 years ago |
|
407
Veracyte
VCYT
$2.52B
|
SJN
Sung Ji Nam
| $31.99 | $42 |
31%
upside
| Buy |
4 Nov ‘20
4 years ago |
|
408
Aldeyra Therapeutics
ALDX
$346M
| $5.76 | $29 |
403%
upside
| Buy |
16 Oct ‘20
4 years ago |
|
|
409
Personalis
PSNL
$478M
| $5.39 | $35 |
549%
upside
| Buy |
8 Oct ‘20
4 years ago |
|
|
410
MediWound
MDWD
$177M
|
RZ
Ryan Zimmerman
| $16.29 | $42 |
158%
upside
| Buy |
23 Sep ‘20
5 years ago |
|
411
89bio
ETNB
$1.28B
|
TS
Thomas Shrader
| $8.63 | $58 |
572%
upside
| Buy |
15 Sep ‘20
5 years ago |
|
412
ACI Worldwide
ACIW
$5.29B
|
MP
Mark Palmer
| $51.23 | $34 |
34%
downside
| Buy |
11 Sep ‘20
5 years ago |
|
|
RDHL
413
Redhill Biopharma
RDHL
$3.26M
|
RH
Robert Hazlett
| $1.42 | $26,000 |
1,830,886%
upside
| Buy |
11 Sep ‘20
5 years ago |
|
414
Akebia Therapeutics
AKBA
$795M
|
RH
Robert Hazlett
| $3 | $6 |
100%
upside
| Buy |
4 Sep ‘20
5 years ago |
|
415
Beam Global
BEEM
$46.4M
|
GL
Gregory Lewis
| $2.58 | $25 |
869%
upside
| Buy |
26 Aug ‘20
5 years ago |
|
416
electroCore
ECOR
$38.5M
|
RZ
Ryan Zimmerman
| $5.08 | $52.50 |
933%
upside
| Buy |
14 Aug ‘20
5 years ago |
|
417
Senseonics Holdings
SENS
$362M
|
MT
Maria Thibault
| $0.4440 | $1 |
125%
upside
| Buy |
11 Aug ‘20
5 years ago |
|
418
NextCure
NXTC
$13.6M
| $5.07 | $324 |
6,291%
upside
| Buy |
14 Jul ‘20
5 years ago |
|
|
419
Avita Medical
RCEL
$113M
| $4.19 | $41 |
879%
upside
| Buy |
9 Jul ‘20
5 years ago |
|
|
420
Amicus Therapeutics
FOLD
$2.43B
|
DGH
Dae Gon Ha
| $7.89 | $19 |
141%
upside
| Buy |
17 Jun ‘20
5 years ago |
|
421
Fulcrum Therapeutics
FULC
$392M
|
DGH
Dae Gon Ha
| $7.24 | $27 |
273%
upside
| Buy |
17 Jun ‘20
5 years ago |
|
422
InflaRx
IFRX
$104M
|
DGH
Dae Gon Ha
| $1.53 | $12 |
684%
upside
| Buy |
17 Jun ‘20
5 years ago |
|
423
Travere Therapeutics
TVTX
$1.93B
|
DGH
Dae Gon Ha
| $21.64 | $25 |
16%
upside
| Buy |
17 Jun ‘20
5 years ago |
|
424
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.43B
|
GL
Gregory Lewis
| $27.62 | $40 |
45%
upside
| Buy |
16 Jun ‘20
5 years ago |
|
|
PINE
425
Alpine Income Property Trust
PINE
$215M
| $15.19 | $18 |
19%
upside
| Buy |
4 Jun ‘20
5 years ago |
|